baber/WOPTO huggingface dataset:
Patent AU-2010200054-B2 (AU)
Title: Dispensing device for milk and/ or foam and a coffee machine comprising such a dispensing device
Inventor: PHILIPP BUTTIKER
IPC: B01F25/46
Filed: 2010-01-07
Granted: 2012-01-12
Abstract: Abstract The dispensing device (10) for milk and/or milk foam 5 comprises a mixing device (11) for mixing steam, milk and/or air, the mixing device (11) comprising: a chamber (19), a first line (15) for the supply of milk into the chamber (19), a second line (16) for the supply of steam into the chamber (19), a third line (17) for the supply of air into 10 the chamber (19), at least one outlet (30, 30.1) for dispensing the milk and/or the milk foam from the chamber (19), a valve (21) comprising an adjustable regulating shaft (22) for regulating the supply of milk and/or air into the chamber (19), by adjusting the regulating shaft (22) between 15 different predetermined positions at least one flow of milk being able to be switched on and switched off and/or altered and a flow of air being able to be switched on and switched off and/or altered. The dispensing device (10) further comprises a drive motor (25) for adjusting the regulating 20 shaft (22) of the valve (21) and a control device (35) for controlling the drive motor (25), the regulating shaft (22) being able to be moved by controlling the drive motor (25) by means of the control device (35) into the respective predetermined positions. (Fig. 3) 36-D 37 ---- 5 6' -- 6 30'-30 E]Fig 10
Patent AU-2010203103-B2 (AU)
Title: Collapsible core, filter, and method
Inventor: MERRITT STEVEN J
IPC: B01D29/11
Filed: 2010-07-21
Granted: 2014-02-20
Abstract: A collapsible winding core for a filter element is provided. A fluted filter media is wound about the collapsible winding core having a cylindrical shape. Subsequently, the collapsible winding core is collapsed into a generally flat shape to from the filter element having a racetrack shape. Steven J. Merritt Attorney Docket No. 506897 Teipehone No. (815) 633-5300
Patent AU-2010207074-B2 (AU)
Title: Plug for setting in a pipe
Inventor: HOLSTAD EVALD
IPC: F16L55/136
Filed: 2010-01-20
Granted: 2013-05-23
Abstract: A pipe plug (2, 2', 2'') comprising a shaft (8, 8', 8''); a force transmission body (14) disposed in a rotatable and axially movable manner about the shaft (8, 8', 8'') via a thread connection (16); and a stop body (18). Between the force transmission body (14) and the stop body (18) there is a first compression body (20, 20') disposed in an axially movable manner about the shaft (8, 8', 8'') in proximity of the force transmission body (14); a conical support body (22) disposed in an axially movable manner about the shaft (8, 8', 8''); at least one movable anchoring body (24) on the outside of the support body (22); a second compression body (26) disposed in an axially movable manner about the shaft (8, 8', 8''); and at least one elastic sealing body (28) disposed about the shaft (8, 8', 8''). The shaft (8, 8', 8'') and the first compression body (20, 20') are in direct contact with each other, and the shaft (8, 8', 8'') and the first compression body (20, 20') are connected in a non-rotational manner via complementary connection elements (30', 30''). This prevents the compression body (20, 20') from rotating for optimum transmission and control of an activation force for the plug (2, 2', 2'').
Patent AU-2010224939-B2 (AU)
Title: Method for producing rigid polyurethane foams
Inventor: TOMOVIC ZELJKO
IPC: C08G18/48
Filed: 2010-03-16
Granted: 2015-05-14
Abstract: The invention relates to a method for producing rigid polyurethane foams, wherein a mixture of one or more highly functional polyether alcohols having functionalities of (3.5) to (5.5) and a hydroxyl value of (350) to (550) mg KOH/g, one or more polyether alcohols based on aliphatic and/or aromatic amines having functionalities of (3) to (4) and a hydroxyl value of (150) to (800) mg KOH/g, a fatty acid ester containing OH groups, and optionally one or more low-molecular-weight chain extenders and/or cross-linking agents having functionalities of (2) to (3) and a molecular weight M
Patent AU-2010233089-B2 (AU)
Title: Par-1 activation by metalloproteinase-1 (MMP-1)
Inventor: KULIOPULOS ATHAN
IPC: A61K38/16
Filed: 2010-04-12
Granted: 2016-05-26
Abstract: Matrix metalloproteases (MMPs) play many important roles in normal and pathological remodeling processes including atherothrombotic disease, inflammation, angiogenesis and cancer. This invention relates to the activation of protease-activated receptor-1 (PAR-1) by endogenous platelet MMP-1 collagenase on the surface of platelets. Exposure of platelets to fibrillar collagen converts the surface-bound pro-MMP-1 zymogen to active MMP-1, which promotes aggregation through PAR-1, MMP-1 is shown to cleave the PAR-1 extracellular domain at a novel site, which then strongly activates Rho-GTP signaling pathways, cell shape change and motility, and MAPK signaling. Blockade of MMP-PAR 1 suppresses thrombogenesis under arterial flow conditions and inhibited thrombosis in animals. These studies provide a link between matrix-dependent activation of metalloproteases and platelet-G protein signaling and identify MMP- 1/PAR-1 as a new target for the treatment and prevention of arterial thrombosis and other thrombotic diseases.
Patent AU-2010249784-B2 (AU)
Title: Diagnostic system
Inventor: PHAM HUNG M
IPC: F04B49/06
Filed: 2010-05-18
Granted: 2015-09-03
Abstract: A compressor is provided and may include a shell, a compression mechanism, a motor, and a diagnostic system that determines a system condition. The diagnostic system may include a processor and a memory and may predict a severity level of the system condition based on at least one of a sequence of historical-fault events and a combination of the types of the historical-fault events.
Patent AU-2010250011-B2 (AU)
Title: Hydroconversion process with alkyl halide comprising at least 55 wt% halide
Inventor: HOMMELTOFT SVEN IVAR
IPC: C07C1/30
Filed: 2010-04-29
Granted: 2014-06-05
Abstract: A process comprising: contacting a blend of hydrocarbons under hydroconversion conditions in a hydroconversion zone with a mixture of an acidic ionic liquid catalyst and at least one alkyl halide comprising at least 55 wt% halide and having a boiling point of 70°C or higher. An alkylation process comprising: contacting a blend of hydrocarbons under alkylation conditions with a mixture of an acidic ionic liquid catalyst that is a chloroaluminate and at least one alkyl halide comprising 1,1,1 trichloroethane, tetrachloroethylene, or a mixture thereof; wherein greater than 99.9 wt% of an at least one olefin in the blend of hydrocarbons is alkylated. Also, a hydroconversion process comprising drying the alkyl halide.
Patent AU-2010256810-B2 (AU)
Title: Workgroup key wrapping for community of interest membership authentication
Inventor: JOHNSON ROBERT
IPC: H04L29/06
Filed: 2010-06-01
Granted: 2015-07-09
Abstract: Methods and systems for managing a community of interest are disclosed. One method includes creating a workgroup key associated with a community of interest, and protecting one or more resources associated with the community of interest using the workgroup key. The method also includes encrypting the workgroup key using a public key associated with an administrator of the community of interest, the public key included with a private key in a public/private key pair associated with the administrator. The method further includes storing the encrypted workgroup key and associating the workgroup key with a user, thereby adding the user to the community of interest.
Patent AU-2010264522-B2 (AU)
Title: Improved container labels
Inventor: NEWMAN LINDA
IPC: G09F3/02
Filed: 2010-06-22
Granted: 2016-04-28
Abstract: Improved labels are disclosed for containers of the type defined at least in part by at least one sidewall having an outer surface. The outer surface has at least one label thereon, the label comprising a first writing surface defined by a plurality of individual writing areas arranged in an array characterized in that adjacent writing areas are at least substantially isolated from each other by an intermediate space, and a second writing surface in the intermediate space. The second writing surface is vertically recessed relative to the first writing surface.
Patent AU-2010303010-B2 (AU)
Title: A washing machine with improved rinsing and spin-drying performances
Inventor: DORA MURAT CEMAL
IPC: D06F35/00
Filed: 2010-09-29
Granted: 2014-06-05
Abstract: The washing machine (1 ) of the present invention comprises a drum (2) wherein the laundry to be washed is placed, and a control unit (3) which executes the washing program, consisting of main washing, rinsing and spin-drying steps, at the spin speed determined by the producer according to the washing program that is selected by the user.
Patent AU-2010316669-B2 (AU)
Title: Carboxy oxazole or thiazole compounds as DGAT - 1 inhibitors useful for the treatment of obesity
Inventor: JADHAV RAVINDRA DNYANDEV
IPC: A61K31/421
Filed: 2010-11-01
Granted: 2014-10-23
Abstract: The present invention relates to novel heteroaryl compounds of formula (I), processes for their preparation, pharmaceutical compositions containing them and their use in^the treatment of diseases or disorders mediated by Diacylglycerol acyltransferase 1 enzyme. (DGAT-1), particularly obesity or an obesity related disorder. (I), wherein, Z is selected from unsubstituted or substituted alkylcycloalkyl, unsubstituted or substituted cycloalkyl, unsubstituted or substituted aryl, unsubstituted or substituted heteroaryl and unsubstituted or substituted heterocycle; Y is selected from -Ν(R
Patent AU-2010316982-B2 (AU)
Title: Novel viral vector construct for neuron specific continuous DOPA synthesis in vivo
Inventor: BJORKLUND TOMAS
IPC: C12N15/86
Filed: 2010-11-09
Granted: 2013-09-12
Abstract: The present invention relates to a one-vector expression system comprising a sequence encoding two polypeptides, such as tyrosine hydroxylase (TH) and GTP- cyclohydrolase 1 (GCH1 ). The two polypeptides can be should preferentially be expressed at a ratio between 3:1 and 15:1, such as between 3:1 and 7:1. The invention is useful in the treatment of catecholamine deficient disorders, such as dopamine deficient disorders including but not limited to Parkinson's Disease. Moreover, the present invention provides a method to deliver the vector construct in order to limit the increased production of the catecholamine to the cells in need thereof.
Patent AU-2010342406-B2 (AU)
Title: Elevator system having a cabin-side extinguishing water drain system
Inventor: BLOCH HANSPETER
IPC: B66B13/30
Filed: 2010-12-17
Granted: 2015-01-22
Abstract: The invention relates to a drain system (200a, 200b) in an elevator system (100a, 100b) having at least one elevator cabin (2a, 2b) having an upper edge (27, 27a) running approximately parallel to a horizontal (H, H1), wherein a deflector plate (22, 22a) is arranged on the upper edge of the elevator cabin at at least one angle of inclination (W1 -W4) to the horizontal and is inclined against a shaft wall (15c, 15e), in which shaft doors (9a, 9b, 10a, 10b) are arranged, so that extinguishing water, which falls onto the elevator cabin is directed at least partially from the deflector plate against the upper edge and against the shaft wall in which shaft doors are arranged.
Patent AU-2010349580-B2 (AU)
Title: Low-temperature sintered silver nanoparticle composition and electronic articles formed using the same
Inventor: JABLONSKI GREGORY A
IPC: C09C1/00
Filed: 2010-08-27
Granted: 2014-06-26
Abstract: (16) (43) [ !EW8 2012 W3 i I(01.03.2012) PCT WO 2012/026033 A1 (51) ffd r} : OWATI&9 FM=9A*A W4 Tokyo(JP). 822F 9/OO(2006.01) B22F1/00(206.01) m MAS(FUJITA Hidefumi) [JP/JP]; T 1010021 W it@=M fl4* VTH1 4S1 D (21) $$M*v: PCT/JP2010/064556 OWALIr FD0Z9.44A* t Tokyo(JP). (22) EIjB 2010 89g 27 (27.02010) (74) It 31 A * IE Mf(HIROKOH, Masaki); T (25) E MO*w: 5300047 X 9R| 7 t* Lt PK E T;li 3 T H 1 T 6 (26) Ol *0 FxjHf ld)l Osaka(JP). (81) Th O50LR9, ±tOR Oh0Nt (71) A Si - Dk 0I19): AE, AG, AL, AM, AO, AT, AU, AZ, BA, O W A M L - F 0 I = 9 7 A * 4t (DOWA BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, ELECTRONICS MATERIALS CO., LTD.) [JP/JPI]; CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, F, T 1010021 ** -Tft Z3$*@ 99T E 1 4V GB , GD, GE, GH, GM, OT, HN, HR, HU, I), IL, IN, IS, 1 - Tokyo uP). E-)- T , 7 ' >1 4 V, 4 JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, '/ 9 (PCHEM ASSOCIATES, INC.) [US/US]; 19020 LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, 9-I7 YN t /+).- [t A 7 4 - F MX, MY, MZ, NA, NG, NI NO, NZ, OM, PE, PG, PH, vania (US). SV, SY, TH, TJ, TM, TN, TR, T, TZ, UA, UG, US, UZ, (72) 94s9 ztJ VC, VN, ZA, ZM, ZW. (75) (8i/MA (* [220\C -): t In> (84) $$ (fiO R t ,M|% RY A) [US/IUS]; 19067 / 7 M k --- K MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW), 7l.-5~7 L- A -- 5 1 3 9 5 Pennsylvania (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM), il - I (US). -?X D M I1D, '<4q-)l. I-(MAS- (AL, AT,E, B136, CH, CY, CZ, DF, DK, ELE ES, Fl, FR, TROPIETRO MICHAEL A) [US/US]; 08807 =a - GB, OR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, W '/ T7 a - 30 NewJersey(US). 1% BJ, CF, CG, Ct, CM, GA, GN, GQ, GW, ML, MR, NE, S I(SATOKijitaka) [JP/JP]; T100021 WAY SN, TD, TG). - 5Tft @ [K**@ VRTE 1 4# 1 - DOW A M I/, F l 5X . 4t AI Tokyo (JP).B R @ (MIVOSHI Hiromasa) [JP/JP]; T 1010021 - [ IlI- (Czt, 21 0(3)) S~ft E##@ T~l1 4#1-4 D (54) Title: LOW-TEMPERATURE SINTERABLE SILVER NANOPARTICLE COMPOSITION AND ELECTRONIC COMPO NENT FOR MED USING T IAT COMPOSITION (54) Afl)fi 4M:928e i-r2t-T/$ d Z Ad M@ ffLI-C)[9,ttfz%+MA en (57) Abstract: Provided is a silver nanoparticle composition., which is sintered in a short time at low temperatures, has excellent adherence with a substrate, and can construct silver conductive films and wiring that have low resistance. Also provided is a corn ponent using dhe same. The silver nanoparticle composition provided is characterized by die principal component of the solvent being water, the pH of the composition being in a range of 53 - 80, the silver ntanoparticles contained in that composition being C protected by organic acids or derivatives thereof, and the content for these organic acids or derivatives thereof being in a range of e 2 - 20% by mass of the silver. O(57) t: IIlw|ilt-Cs#i'ib to E' 9 -*9 h\2t4A $l--
Patent AU-2011203536-B2 (AU)
Title: Survivin peptide vaccine
Inventor: ANDERSEN MADS HALD
IPC: C07K14/47
Filed: 2011-07-13
Granted: 2012-11-15
Abstract: r D-oqnU4 Abstract The present invention relates to a therapeutic vaccine comprising one or more survivin 5 polypeptide fragments. The vaccine can be used for prophylactic, ameliorating and/or curative treatment of e.g. cancer diseases. The invention further relates to methods of combination treatment. Fig. 1 -C -c C n CV) Co -p a 0 a o z C 0 o E = 0 = C, cc a, a, o 0 0 0 0 0 0 0 o 0 0 0 0 0 0 ~ CO LC) t CV) r~I VOOL/SIISO Butsnoiea 6Jf4~JoJGqwI1f4
Patent AU-2011209333-B2 (AU)
Title: Oxygen-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
Inventor: RUF SVEN
IPC: C07D417/12
Filed: 2011-01-26
Granted: 2014-12-11
Abstract: The present invention relates to compounds of the formula I, wherein A, D, E, G, R
Patent AU-2011267765-B2 (AU)
Title: Electrode and dye-sensitized solar cell
Inventor: MATHIESON GRANT ALEXANDER
IPC: H01L31/042
Filed: 2011-06-17
Granted: 2013-10-03
Abstract: A working electrode and dye sensitized solar (DSSC) cell having working electrode where the working electrode includes a porous metal foil conductor and a particulate metal oxide layer on the side of the foil for facing incident light and process for preparing the electrode and DSSC.
Patent AU-2011273931-B2 (AU)
Title: 2,4- diaryl - substituted [1,8] naphthyridines as kinase inhibitors for use against cancer
Inventor: DORSCH DIETER
IPC: C07D519/00
Filed: 2011-05-31
Granted: 2015-04-23
Abstract: The present invention relates to novel [1,8]naphthyridine derivatives of formula (I) and to the use of such compounds in which the inhibition, regulation and/or modulation of signal transduction by ATP consuming proteins like kinases plays a role, particularly to inhibitors of TGF-beta receptor kinases, and to the use of such compounds for the treatment of kinase-induced diseases, in particular for the treatment of tumors.
Patent AU-2011336500-B2 (AU)
Title: Novel topical composition of Sarracenia purpurea (pitcher plant)
Inventor: GOWIE BRANDY
IPC: A01N65/00
Filed: 2011-12-01
Granted: 2016-01-07
Abstract: A composition having a pitcher plant component and a fatty acid component, wherein the pitcher plant component is an alcohol extract, the pitcher plant component further comprises a preservative component, the pitcher plant component is prepared through a soak and press technique and prepared through steam distillation, the composition of claim 1 being a topical or suppository formulation.
Patent AU-2011347095-B2 (AU)
Title: Non-coding immunomodulatory DNA construct
Inventor: SCHROFF MATTHIAS
IPC: C12N15/117
Filed: 2011-12-23
Granted: 2016-04-28
Abstract: The present invention relates to a nucleic acid molecule and its use for the modulation of the immune system. It provides a DNA construct for immunomodulation comprising at least one nucleotide in L-conformation.
Patent AU-2011361876-B2 (AU)
Title: Power conversion device and refrigeration/AC system
Inventor: ARISAWA KOICHI
IPC: H02M3/155
Filed: 2011-03-04
Granted: 2015-02-12
Abstract: This power conversion device is provided with a power source (1), a boosting means (a reactor (21) and a switch (22)) for boosting by switching control the voltage supplied from the power source (1), a smoothing circuit (3) for smoothing the voltage output from the boosting means, a rectifier (23) disposed between the booster means and the smoothing circuit (3) for preventing the reverse flow of current to the boosting means, and a commutation means (4) which, connected in parallel to the rectifier (23), reverses the current flowing to the rectifier (23) to flow towards said commutation means (4).
Patent AU-2011363023-B2 (AU)
Title: Reduced sodium salt composition
Inventor: MURRAY RICHARD DURNO
IPC: A23L33/20
Filed: 2011-10-26
Granted: 2015-11-05
Abstract: The invention allows for a reduction in the amount of sodium chloride applied to a food product, without adversely affecting the taste of the food product. Sodium chloride particles with bi-modal particle size distribution are combined with particles of another edible salt with a particle size distribution peak that falls between the bi-modal peaks of the sodium chloride particles. In this way, any off-flavors exhibited by the other edible salt are masked by the initial and final pure sodium chloride saltiness flavors provided by the composition.
Patent AU-2012202878-B2 (AU)
Title: Patient support
Inventor: BOBEY JOHN ALAN
IPC: A47C27/10
Filed: 2012-05-16
Granted: 2013-01-24
Abstract: Abstract The present invention relates to a device for supporting a patient, such as a mattress. In particular, the present invention relates to patient supports appropriate for use in hospitals, acute care facilities, and other patient care environments. Further, the present 5 invention relates to pressure relief support surfaces and support surfaces that are configured to accommodate and operate with a variety of sizes and styles of beds, bed frames, and patient types. The specification describes certain exemplary embodiments of a patient support having a plurality of vertically-oriented on substantially can-shaped inflatable bladders. In one 10 embodiment, the patient support includes a support layer positioned above the vertical bladders. In another embodiment, the patient support includes a high air loss device. In still another embodiment, the patient support includes a pneumatic device located within the patient support. 15 Fig. I ccJ
Patent AU-2012203219-B2 (AU)
Title: Induction of arteriogenesis
Inventor: GORATH MICHAELA
IPC: A61P9/10
Filed: 2012-05-31
Granted: 2014-10-09
Abstract: Abstract The present invention inter alia relates to a method of promoting collateral circulation comprising the step of exposing a subject to a therapeutically effective amount of an NO 5 donor wherein the therapeutically effective amount of the NO donor promotes arteriogenesis sufficient to augment collateral circulation in a physiological or pathological condition.
Patent AU-2012203535-B2 (AU)
Title: Method and apparatus for controlling hybrid electric vehicles
Inventor: SCHULTE JURGEN
IPC: B60L50/16
Filed: 2012-06-18
Granted: 2014-11-06
Abstract: A method for operating an engine and an integrated starter/generator/motor (ISGM) disposed in a hybrid electric vehicle, which includes launch and deceleration processes. The ISGM is used to both launch the vehicle and start the engine. The deceleration process includes operating a first clutch to disengage the engine from the ISGM during an initial phase, and engaging a second clutch during the initial phase to direct substantially all regenerative energy to provide the only source of electrical energy to recharge the energy storage device. x 0 mo 2 am aL e . c 0 Em | 00 -o c _, EW o e< [i"i
Patent AU-2012210593-B2 (AU)
Title: Systems and methods for medical use of motion imaging and capture
Inventor: VARAKLIS JOHN
IPC: A61B5/11
Filed: 2012-01-23
Granted: 2016-12-08
Abstract: A motion sensing and capture system to provide to a patient and/or healthcare provider, patient motion data and/or motion impairment data, which can be used as a diagnostic, predictive or therapeutic tool. Such method comprises the steps of: (a) selecting one or more patient motions; (b) using a sensing and capture system to image an initial set comprising the one or more motions to provide an initial set of motion data; and (c) conveying such initial set of motion data to a patient and/or healthcare provider.
Patent AU-2012217033-B2 (AU)
Title: Pto transmission system in an agricultural or industrial vehicle and method of operating thereof
Inventor: HUBER CHRISTIAN
IPC: F16H47/04
Filed: 2012-02-16
Granted: 2015-11-05
Abstract: A PTO transmission system in a vehicle for transmitting power to a PTO shaft driving an implement comprises a planetary drive unit (3) having first and second input means (2, 5) and output means (4) coupled to the PTO shaft (8). The first and second input means are coupled to an output shaft of the vehicle engine (1) and to an output shaft (5) of drive motor means (7), respectively. Control means (11) control the transfer of power from a power source (4) to said drive motor means (7). The power source is a variable power generating means (6) driven by said PTO shaft. The drive motor means are configured and adapted to decrease or increase the rotational speed of the output means of the planetary drive unit on an increase or decrease of the power transferred to it, respectively.
Patent AU-2012227350-B2 (AU)
Title: HLA-A*1101-Restricted WT1 peptide and pharmaceutical composition comprising the same
Inventor: SUGIYAMA HARUO
IPC: C12N15/12
Filed: 2012-09-26
Granted: 2015-03-19
Abstract: C XNRPonhnD)C(AARW 2"'>_1 I)OC-9'252 1.' -38 A BST RA CT The present invention relates to an lLA-A*l 101-restricted WTI peptide, specifically, a peptide comprising an amino acid ;equencc consisting of 9 contiguous amino acids from a WT1 protein, wherein the peptide has an ability to bind to an HlLA-A*l 101 molecule, and has an ability to induce a CTL. The present invention also relates to a peptide dimer having an ability to bind to an HlIA-A*I 101 molecule and having an ability to induce a CTL, in which two peptide monomers each comprising an amino acid sequence consisting of 9 contiguous amino acids from a WTI protein and comprising at least one cysteine residue are bound to each other through a disulfide bond. Furthermore, the present invention relates to a polynuclcotide encoding the peptide, a pharmaceutical composition for the treatment and/or prevention of a cancer comprising the same and the like.